Selective Liver Estrogen Receptor α Modulation Prevents Steatosis, Diabetes, and Obesity Through the Anorectic Growth Differentiation Factor 15 Hepatokine in Mice

Hepatocyte estrogen receptor α (ERα) was recently recognized as a relevant molecular target for nonalcoholic fatty liver disease (NAFLD) prevention. The present study defined to what extent hepatocyte ERα could be involved in preserving metabolic homeostasis in response to a full (17β‐estradiol [E2]...

Descripción completa

Detalles Bibliográficos
Autores principales: Guillaume, Maeva, Riant, Elodie, Fabre, Aurélie, Raymond‐Letron, Isabelle, Buscato, Melissa, Davezac, Morgane, Tramunt, Blandine, Montagner, Alexandra, Smati, Sarra, Zahreddine, Rana, Palierne, Gaëlle, Valera, Marie‐Cécile, Guillou, Hervé, Lenfant, Françoise, Unsicker, Klaus, Metivier, Raphaël, Fontaine, Coralie, Arnal, Jean‐François, Gourdy, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601326/
https://www.ncbi.nlm.nih.gov/pubmed/31304450
http://dx.doi.org/10.1002/hep4.1363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601326/
https://www.ncbi.nlm.nih.gov/pubmed/31304450
http://dx.doi.org/10.1002/hep4.1363

Ejemplares similares